Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ADMA – Adma Biologics Inc

ADMA Biologics Inc
ADMA
$19.33
Name : ADMA Biologics Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $4,614,728,192.00
EPSttm : 0.84
finviz dynamic chart for ADMA
ADMA Biologics Inc
$19.33
3.37%
$0.63

Float Short %

6.28

Margin Of Safety %

33

Put/Call OI Ratio

0.44

EPS Next Q Diff

0.06

EPS Last/This Y

-0.25

EPS This/Next Y

0.35

Price

19.33

Target Price

32.33

Analyst Recom

1

Performance Q

-16.93

Relative Volume

0.8

Beta

0.38

Ticker: ADMA




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04ADMA18.280.430.4263814
2025-07-07ADMA17.880.420.2063925
2025-07-08ADMA17.810.420.3464178
2025-07-09ADMA18.350.431.4664458
2025-07-10ADMA18.490.430.3764880
2025-07-11ADMA18.530.430.0665036
2025-07-14ADMA18.680.430.9065538
2025-07-15ADMA17.980.430.1365755
2025-07-16ADMA17.670.430.4266008
2025-07-17ADMA17.580.420.2467113
2025-07-18ADMA16.690.413.3267248
2025-07-21ADMA17.140.440.3265598
2025-07-22ADMA17.060.430.1166780
2025-07-23ADMA17.20.430.2867302
2025-07-24ADMA17.310.430.6467626
2025-07-25ADMA18.010.430.7367811
2025-07-28ADMA18.020.450.5769236
2025-07-29ADMA18.270.440.1169416
2025-07-30ADMA18.590.440.1269788
2025-07-31ADMA18.720.440.2070076
2025-08-01ADMA19.320.440.5670125
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04ADMA18.287.7- 0.61
2025-07-07ADMA17.867.7- 0.61
2025-07-08ADMA17.817.7- 0.61
2025-07-09ADMA18.347.7- 0.61
2025-07-10ADMA18.477.7- 0.61
2025-07-11ADMA18.517.7- 0.61
2025-07-14ADMA18.687.7- 0.61
2025-07-15ADMA17.987.7- 0.61
2025-07-16ADMA17.677.7- 0.61
2025-07-17ADMA17.597.7- 0.61
2025-07-18ADMA16.747.7- 0.61
2025-07-21ADMA17.137.7- 0.61
2025-07-22ADMA17.057.7- 0.61
2025-07-23ADMA17.207.7- 0.61
2025-07-24ADMA17.313.9- 0.60
2025-07-25ADMA18.013.9- 0.60
2025-07-28ADMA18.023.9- 0.60
2025-07-29ADMA18.263.9- 0.60
2025-07-30ADMA18.593.9- 0.60
2025-07-31ADMA18.703.9- 0.60
2025-08-01ADMA19.333.9- 0.60
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04ADMA-6.260.165.99
2025-07-07ADMA-6.260.165.99
2025-07-08ADMA-6.260.165.99
2025-07-09ADMA-6.260.165.99
2025-07-10ADMA-6.260.165.99
2025-07-11ADMA-6.260.167.04
2025-07-14ADMA-6.262.067.04
2025-07-15ADMA-6.262.067.04
2025-07-16ADMA-6.262.067.04
2025-07-17ADMA-6.492.067.04
2025-07-18ADMA-6.492.067.04
2025-07-21ADMA-6.491.587.04
2025-07-22ADMA-6.501.587.04
2025-07-23ADMA-6.501.587.04
2025-07-24ADMA-6.501.587.04
2025-07-25ADMA-6.501.586.28
2025-07-28ADMA-6.500.346.28
2025-07-29ADMA-6.500.346.28
2025-07-30ADMA-6.500.346.28
2025-07-31ADMA-6.500.346.28
2025-08-01ADMA-6.500.346.28
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.11

Avg. EPS Est. Current Quarter

0.14

Avg. EPS Est. Next Quarter

0.17

Insider Transactions

-6.5

Institutional Transactions

0.34

Beta

0.38

Average Sales Estimate Current Quarter

122

Average Sales Estimate Next Quarter

130

Fair Value

25.8

Quality Score

99

Growth Score

81

Sentiment Score

97

Actual DrawDown %

24.7

Max Drawdown 5-Year %

-69.5

Target Price

32.33

P/E

22.9

Forward P/E

20.64

PEG

0.6

P/S

10.05

P/B

12.35

P/Free Cash Flow

50.91

EPS

0.84

Average EPS Est. Cur. Y​

0.6

EPS Next Y. (Est.)

0.96

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

45.01

Relative Volume

0.8

Return on Equity vs Sector %

31.6

Return on Equity vs Industry %

50.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

ADMA Biologics Inc
Sector: Healthcare
Industry: Biotechnology
Employees: 685
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
stock quote shares ADMA – Adma Biologics Inc Stock Price stock today
news today ADMA – Adma Biologics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ADMA – Adma Biologics Inc yahoo finance google finance
stock history ADMA – Adma Biologics Inc invest stock market
stock prices ADMA premarket after hours
ticker ADMA fair value insiders trading